aid: babylon-bio
name: Babylon Bio
description: 'Babylon Bio (Babylon Biosciences) is a San Francisco-based drug discovery and development
  company founded in 2023 and backed by Lux Capital. Staffed by experienced medicinal chemists and
  biologists with a track record of discovering FDA-approved medicines, the company develops
  therapeutics that rescue essential functions in the brain rather than clearing emergent pathology,
  leveraging a proprietary high-throughput assay platform with an early focus on neurodegenerative
  disease including Alzheimer''s. It was surfaced as a portfolio company of Lux Capital and added to
  the API Evangelist network. As a private, pre-commercial biotech it publishes no public API,
  developer portal, or documentation surface at this time.'
url: https://raw.githubusercontent.com/api-evangelist/babylon-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lux-capital
x-tier: stub
x-tier-reason: portfolio-lead
x-enrichment-status: 'no-api-surface: identity-only biotech; verified no public API/docs/well-known as of 2026-07-18'
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://cdn.prod.website-files.com/660078e1a7370d500b5e719d/67e99045ff17f5c0923513db_babylon_hero.webp
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotech
- Drug Discovery
- Pharmaceuticals
- Therapeutics
- Neuroscience
- Life Sciences
- Alzheimer's
apis: []
common:
- type: Website
  url: https://babylon.bio
- type: LinkedIn
  url: https://www.linkedin.com/company/babylon-bio/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence